Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Safran

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Current Oncology Reports|April 19, 2006
Multimodality treatment of esophageal cancer: a review of the current status and future directionsThomas Ng, Thomas Dipetrillo, John Purviance, et al.
Cancer|August 1, 2006
Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancerWallace Akerley, Howard Safran, Ken Zaner, et al.
JCO Oncology Practice|August 19, 2022
Objective Impact of Hematology-Oncology Hospitalist Care in an Inpatient SettingKristina A Fanucci, Andrew Yang, Alison Chambers, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2003
Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trialsChristopher G Willett, Howard Safran, Ross A Abrams, et al.
American Journal of Clinical Oncology|September 1, 2007
A phase I study of docetaxel, oxaliplatin, and capecitabine in patients with metastatic gastroesophageal cancerDevon Evans, Tom Miner, Paul Akerman, et al.
Cancer|October 31, 2002
A phase I study of a weekly schedule of paclitaxel and carboplatin in patients with advanced carcinomaWallace Akerley, Ritesh Rathore, Neil Ready, et al.
Journal of Hepatology|January 17, 2012
Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinomaMasafumi Shimoda, Yoshito Tomimaru, Kevin P Charpentier, et al.
Oncotarget|February 6, 2019
<i>ROS1-GOPC/FIG</i>: a novel gene fusion in hepatic angiosarcomaEric I Marks, Sahithi Pamarthy, Don Dizon, et al.
American Journal of Clinical Oncology|August 19, 2009
Phase I study of hepatic arterial infusion of oxaliplatin in advanced hepatocellular cancer: a brown university oncology group studyRitesh Rathore, Howard Safran, Greg Soares, et al.
Oncotarget|May 26, 2023
Addendum: <i>ROS1-GOPC/FIG</i>: a novel gene fusion in hepatic angiosarcomaEric I Marks, Sahithi Pamarthy, Don Dizon, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Current Oncology Reports|April 19, 2006
Multimodality treatment of esophageal cancer: a review of the current status and future directionsThomas Ng, Thomas Dipetrillo, John Purviance, et al.
Cancer|August 1, 2006
Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancerWallace Akerley, Howard Safran, Ken Zaner, et al.
JCO Oncology Practice|August 19, 2022
Objective Impact of Hematology-Oncology Hospitalist Care in an Inpatient SettingKristina A Fanucci, Andrew Yang, Alison Chambers, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2003
Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trialsChristopher G Willett, Howard Safran, Ross A Abrams, et al.
American Journal of Clinical Oncology|September 1, 2007
A phase I study of docetaxel, oxaliplatin, and capecitabine in patients with metastatic gastroesophageal cancerDevon Evans, Tom Miner, Paul Akerman, et al.
Cancer|October 31, 2002
A phase I study of a weekly schedule of paclitaxel and carboplatin in patients with advanced carcinomaWallace Akerley, Ritesh Rathore, Neil Ready, et al.
Journal of Hepatology|January 17, 2012
Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinomaMasafumi Shimoda, Yoshito Tomimaru, Kevin P Charpentier, et al.
Oncotarget|February 6, 2019
<i>ROS1-GOPC/FIG</i>: a novel gene fusion in hepatic angiosarcomaEric I Marks, Sahithi Pamarthy, Don Dizon, et al.
American Journal of Clinical Oncology|August 19, 2009
Phase I study of hepatic arterial infusion of oxaliplatin in advanced hepatocellular cancer: a brown university oncology group studyRitesh Rathore, Howard Safran, Greg Soares, et al.
Oncotarget|May 26, 2023
Addendum: <i>ROS1-GOPC/FIG</i>: a novel gene fusion in hepatic angiosarcomaEric I Marks, Sahithi Pamarthy, Don Dizon, et al.
Pageof 12